Singapore-headquartered private equity (PE) firm Quadria Capital is in advanced talks to invest in India’s Maxivision Super Speciality Eye Hospitals, run by serial healthcare entrepreneur GSK Velu, in a deal that will value the firm at about Rs 1200 crore ($145 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
